Pharmalex US Corporation

Conshohocken, PA Pharmalex US Corp Part of Cencora, Inc.

UEI
XFLXMFKCJQN1
CAGE
884Z0
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
  • Cencora, Inc. Parent NWEGNLYTBDW4
    • Pharmalex US Corporation XFLXMFKCJQN1
SAM.gov registration date
Physical address
1 W 1st Ave, Conshohocken, PA 19428, USA
Website
pharmalex.com
Founded
1994
Employees
1K-5K
Estimated annual revenue
$500M-$1B
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
89 Services, Not Elsewhere Classified
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Pharmalex US Corporation's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Biologics subject matter expert (SME) consulting services Contract · 75N95022P00209 National Institute on Drug Abuse $62,950

Quick answers

What is Pharmalex US Corporation's UEI?

Pharmalex US Corporation's Unique Entity ID (UEI) in SAM.gov is XFLXMFKCJQN1.

What is Pharmalex US Corporation's CAGE code?

Pharmalex US Corporation's CAGE code is 884Z0.

What is Pharmalex US Corporation's primary NAICS code?

Pharmalex US Corporation's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Pharmalex US Corporation located?

Pharmalex US Corporation's physical address in SAM.gov is 1 W 1st Ave, Conshohocken, PA 19428, USA.

Is Pharmalex US Corporation registered in SAM.gov?

Yes. Pharmalex US Corporation's SAM.gov registration is active through March 27, 2027.

Who is Pharmalex US Corporation's parent company?

Pharmalex US Corporation is part of Cencora, Inc.

What is Pharmalex US Corporation's most recent federal award?

Pharmalex US Corporation's most recent federal contract award is Biologics subject matter expert (SME) consulting services (75N95022P00209), from National Institute on Drug Abuse, on April 15, 2022.

On GovTribe

See Pharmalex US Corporation's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login